Speaker illustration

Doctor Harold Bays

Louisville Metabolic and Atherosclerosis Research Center, Louisville (United States of America)

The future of lipid management: new therapies for LDL-C lowering

Event: ESC CONGRESS 2019

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session: Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population

Thumbnail

This platform is supported by

logo Novo Nordisk